MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...
27 Apr, 2021, 04.09 PM IST
Wall Street closes broadly higher on deal news, vaccine hopesDrugmaker AstraZeneca resumed its British clinical trials of its COVID-19 vaccine, one of the most advanced in development.
15 Sep, 2020, 07.52 AM IST
Merck leaps into COVID-19 development fray with vaccine, drug dealsIt also announced a partnership with privately-held Ridgeback Biotherapeutics to develop an experimental oral antiviral drug against COVID-...
26 May, 2020, 04.34 PM IST
Fulford India divests consumer care biz to Bayer Pharmaceuticals Private LtdBayer will completely take over the marketing and distribution of the consumer care products with effect from January 1, 2015, it added.
23 Dec, 2014, 07.46 PM IST
Sun Pharma Q2 net profit up 15% at Rs 1,572 crore"We also continue to review opportunities to expand and strengthen our global footprint,” said Dilip Shanghvi, managing director, Sun Pharm...
14 Nov, 2014, 07.20 AM IST
Sun Pharmaceutical shares end nearly 2 per cent up on Merck & Co Inc licensing pactStock of the pharma firm settled with a gain of 1.63 per cent at Rs 805.20 on the BSE. During the day, it climbed 2.78 per cent to Rs 814.4...
19 Sep, 2014, 07.27 PM IST
Sun Pharma, Merck & Co Inc enter into pact for TildrakizumabUnder terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck.
17 Sep, 2014, 08.05 PM IST
Aurobindo, Glenmark, Natco get USFDA nod for migraine tabletsNatco said the drug shipments were already made and the product is being marketed by its partner Breckenridge Pharmaceuticals in the US mar...
02 Jul, 2013, 05.10 PM IST
Aurobindo Pharma gets USFDA final nod for migraine tabletsAurobindo Pharma today said it has received final approval from the US health regulator to manufacture Rizatriptan Benzoate tablets.
02 Jul, 2013, 01.02 PM IST
- Dr Reddy's launches tablets to treat hair loss
The tablets are bioequivalent generic version of Merck Sharp & Dohme Corp, a subsidiary of Merck & Co Inc's Propecia tablets.
03 Jan, 2013, 03.40 PM IST
- Hilleman Laboratories loses key executives
Some of the top executives, including the founding CEO, have moved on from Delhi-based vaccine research firm Hilleman Laboratories.
21 Nov, 2011, 02.22 AM IST
- Merck, Ranbaxy drug development deal called off
US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, whi...
06 Jan, 2011, 02.44 PM IST
- FDA approves Merck's new lung drug Dulera
Merck & Co Inc's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Th...
24 Jun, 2010, 06.47 PM IST
- Pfizer, Merck to cut 1,700 jobs following mergers
Combined, Pfizer and Wyeth plan to cut about 20,000 jobs, or 15 percent of their combined staff in the future. Top 10 Paymasters | Intervie...
12 Jan, 2010, 12.52 AM IST
- Shasun Chemicals enters non-exclusive deal with Merck
Shasun Chemicals has entered into a non-exclusive licensing agreement with Merck & Co Inc.
27 Feb, 2008, 01.55 PM IST
- Merck & Co signs global multi-services pact with HCL Tech
IT firm HCL Technologies Ltd on Tuesday announced a multi-year, multi-service agreement with Merck & Co Inc, expanding upon the existing re...
18 Dec, 2007, 09.40 PM IST
- Nicholas Piramal, Merck in new drug discovery JV
Nicholas Piramal India Ltd and Merck & Co Inc have entered into a research and development agreement to discover new drugs for two selected...
19 Nov, 2007, 12.05 PM IST